Drug Development at Chugai Pharma USA is part of Chugai's Global Drug Development efforts which include the US, the European Union and Japan. The Drug Development group consists of Pre-clinical Development, Clinical and Medical Affairs, Regulatory Affairs, Pharmaceutical Development, and Quality Assurance and Project Management Departments. Our targeted therapeutic domains include Oncology, Cardiovascular Disease, Osteoporosis, GI disorders, and inflammatory diseases.
